Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
National Institutes of Health Clinical Center (CC)
Tango Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Endeavor Biomedicines, Inc.
University of Nebraska
Perspective Therapeutics
HiFiBiO Therapeutics
Seattle Children's Hospital
Seattle Children's Hospital
St. Jude Children's Research Hospital
Actym Therapeutics, Inc.
Medical College of Wisconsin
University of Pittsburgh
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Cancer Research UK
Columbia University
Children's Oncology Group
SOLTI Breast Cancer Research Group
Mayo Clinic
Ipsen
Taproot Health
University Hospital, Antwerp
Prelude Therapeutics
Memorial Sloan Kettering Cancer Center
Ipsen
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Translational Research in Oncology
Institut Bergonié
Quadriga Biosciences, Inc.
Ascentage Pharma Group Inc.
National Institutes of Health Clinical Center (CC)
MacroGenics
Emory University
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Swiss Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
NYU Langone Health
Memorial Sloan Kettering Cancer Center
Stanford University
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)